SANTIS PHARMA
0421.562.592 · rovalta.com · 08/11/2026
SANTIS PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOSANTIS PHARMA is a Public limited company incorporated in 1981. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Thimister-Clermont. It employs on average 33,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0421.562.592
- Incorporation
- 01/04/1981
- Legal form
- Public limited company
- Registered office
- Rue de l'Avenir 12
4890 Thimister-Clermont · WallonieSee on map - Contributed capital
- 544 305,69 €
- Latest accounts
- 31/12/2025
- Average workforce
- 33,7 ETP
Financials
Source · NBB, 20 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 17,9 M € | -3.6% | 18,6 M € | – | – | – | |||
| EBITDA | 1,9 M € | +71.1% | 1,1 M € | +138% | 470,5 k € | -3.9% | 489,7 k € | +6.0% | 461,8 k € |
| Operating result | 1,7 M € | +93.4% | 877,2 k € | +95.7% | 448,3 k € | +0.6% | 445,5 k € | +2.6% | 434,4 k € |
| Net result | 1,2 M € | +93.8% | 631,4 k € | +94.1% | 325,2 k € | +3.7% | 313,7 k € | +8.8% | 288,2 k € |
| Balance sheet | |||||||||
| Equity | 640,4 k € | -87.9% | 5,3 M € | +643% | 712,5 k € | +84.0% | 387,2 k € | -1.6% | 393,6 k € |
| Total assets | 8,7 M € | -28.8% | 12,2 M € | +576% | 1,8 M € | -23.0% | 2,3 M € | +6.3% | 2,2 M € |
| Cash | 99,1 k € | -34.1% | 150,3 k € | +21.8% | 123,4 k € | -71.2% | 428,6 k € | +53.5% | 279,3 k € |
| Debts | 8 M € | +16.8% | 6,9 M € | +532% | 1,1 M € | -44.3% | 1,9 M € | +8.0% | 1,8 M € |
| Other | |||||||||
| Workforce | 33,7 ETP | +19.9% | 28,1 ETP | +539% | 4,4 ETP | -25.4% | 5,9 ETP | +5.4% | 5,6 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20258 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
BERNARD LEMARCHAND | Director25/08/2025 → 25/08/2031 | ||
CATHERINE DAUBY | Director25/08/2025 → 25/08/2031 | ||
MARC BREYER | Director25/08/2025 → 25/08/2031 | ||
MARIA MAGDALENA GROSCH-HENNES | Director25/08/2025 → 25/08/2031 | ||
MONIQUE SCHMITZ | Director25/08/2025 → 25/08/2031 | ||
| Director25/08/2025 → 25/08/2031 | |||
PHILIPPE GEORIS | Director25/08/2025 → 25/08/2031 | ||
PIERRE DETHIER | Director25/08/2025 → 25/08/2031 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director10/01/2024 → 2024 accountsManaging director01/06/2021 → 2022 accounts | |||
Chantal HARDY | Director01/06/2021 → 2023 accounts |
Other companies at this address
Rue de l'Avenir 12 4890 Thimister-Clermont| Company | CBE no. |
|---|---|
GENERATION 2000● Active | 0432.862.104 |
La Grande Pharmacie● Active | 0402.353.129 |
PHARMACIE DOUCET-STAS● Active | 0859.769.297 |
PHARMACIE LARDINOIS● Active | 0420.259.329 |
| 0402.307.894 | |
PHARMAEXPRESS● Active | 0743.800.651 |
PHARMA FUTUR● Active | 0787.394.827 |
V-IMMO● Active | 0461.767.213 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/04/2026 | 19/05/2025 | 16/07/2024 | 22/05/2023 | 15/07/2022 | 10/06/2021 |
| General meeting | 27/04/2026 | 28/04/2025 | 25/06/2024 | 09/05/2023 | 21/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 27/04/2026 | 28/04/2026 | French | |
| Full model | 31/12/2024 | 28/04/2025 | 19/05/2025 | French | |
| Abridged model | 31/12/2023 | 25/06/2024 | 16/07/2024 | French | |
| Abridged model | 31/12/2022 | 09/05/2023 | 22/05/2023 | French | |
| Abridged model | 31/12/2021 | 21/06/2022 | 15/07/2022 | French | |
| Abridged model | 31/12/2020 | 01/06/2021 | 10/06/2021 | French | |
| Abridged model | 31/12/2019 | 30/06/2020 | 28/08/2020 | French | |
| Abridged model | 31/12/2018 | 29/06/2019 | 10/08/2019 | French | |
| Abridged model | 31/12/2017 | 30/06/2018 | 23/08/2018 | French | |
| Abridged model | 31/12/2016 | 30/06/2017 | 29/08/2017 | French | |
| Abridged model | 31/12/2015 | 30/06/2016 | 20/08/2016 | French | |
| Abridged model | 31/12/2014 | 30/06/2015 | 03/08/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 20/08/2014 | French | |
| Abridged model | 31/12/2012 | 30/06/2013 | 23/08/2013 | French | |
| Abridged model | 31/12/2011 | 30/06/2012 | 28/08/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 02/08/2011 | French | |
| Abridged model | 31/12/2009 | 30/06/2010 | 18/07/2010 | French | |
| Abridged model | 31/12/2008 | 30/06/2009 | 07/08/2009 | French | |
| Abridged model | 31/12/2007 | 30/06/2008 | 15/08/2008 | French | |
| Abridged model | 31/12/2006 | 30/06/2007 | 28/08/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20258 active · 2 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
BERNARD LEMARCHAND | Director25/08/2025 → 25/08/2031 | ||
CATHERINE DAUBY | Director25/08/2025 → 25/08/2031 | ||
MARC BREYER | Director25/08/2025 → 25/08/2031 | ||
MARIA MAGDALENA GROSCH-HENNES | Director25/08/2025 → 25/08/2031 | ||
MONIQUE SCHMITZ | Director25/08/2025 → 25/08/2031 | ||
| Director25/08/2025 → 25/08/2031 | |||
PHILIPPE GEORIS | Director25/08/2025 → 25/08/2031 | ||
PIERRE DETHIER | Director25/08/2025 → 25/08/2031 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director10/01/2024 → 2024 accountsManaging director01/06/2021 → 2022 accounts | |||
Chantal HARDY | Director01/06/2021 → 2023 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office09/09/2026CHANGEMENT DE SIEGE SOCIAL
- Mandates09/09/2025DEMISSIONS, NOMINATIONS
- Mandates29/07/2024DENOMINATION
- Restructuring23/07/2024RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring27/05/2024RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates30/01/2024SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Capital / shares29/07/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates25/06/2021DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de l'Avenir 12, 4890 Thimister-ClermontCurrent | CBE | |
| Rue de Mangombroux 161, 4800 Verviers | accounts 2023 → 2025 | Accounts 2025 · 2026-00098494 |
| Chaussée de Liège 426, 4460 Grâce-Hollogne | accounts 2021 → 2022 | Accounts 2022 · 2023-00093555 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| SANTIS PHARMACurrent | accounts 2024 → 2025 | Accounts 2025 · 2026-00098494 |
| PHARMACIE BUSTIN | accounts 2021 → 2023 | Accounts 2023 · 2024-00254051 |
Events
- 2025Annual accounts 20251,2 M €↑
- 2024Annual accounts 2024631,4 k €↑
- 2024Name changeSANTIS PHARMA
- 2023Annual accounts 2023325,2 k €↑
- 2022Annual accounts 2022313,7 k €↑
- 2021Annual accounts 2021288,2 k €
- 01/04/1981IncorporationPublic limited company